From December 31, 2022 to March 13, 2023, the company has repurchased 2,921,200 shares, representing 0.26% for CNY 100.97 million. With this, the company has completed the repurchase of 3,581,600 shares, representing 0.32% for CNY 120.97 million under the buyback announced on October 12, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.81 CNY | -2.44% | +3.02% | -23.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.35% | 3.3B | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.05% | 32.43B | |
+55.89% | 24.28B | |
-15.93% | 15.52B | |
-41.29% | 12.17B | |
-15.23% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- 300601 Stock
- News Shenzhen Kangtai Biological Products Co., Ltd.
- Tranche Update on Shenzhen Kangtai Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 12, 2022.